Gts Securities LLC Sangamo Therapeutics, Inc Transaction History
Gts Securities LLC
- $45.4 Billion
- Q3 2024
A detailed history of Gts Securities LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Gts Securities LLC holds 51,400 shares of SGMO stock, worth $131,584. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,400
Previous 20,600
149.51%
Holding current value
$131,584
Previous $7,000
528.57%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SGMO
# of Institutions
115Shares Held
56.4MCall Options Held
576KPut Options Held
1.17M-
Wasatch Advisors Inc Salt Lake City, UT19.4MShares$49.8 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.6MShares$24.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.85MShares$12.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$12 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.35MShares$6.03 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $401M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...